English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12189/12972 (94%)
Visitors : 958250      Online Users : 832
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version

    Category

    Loading community tree, please wait....

    Year

    Loading year class tree, please wait....

    Items for Author "Hou, MC" 

    Return to Browse by Author

    Showing 12 items.

    Collection Date Title Relation Bitstream
    [許志成] 期刊論文 2021-06-12 Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis? -
    [許志成] 期刊論文 2022-01 Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis -
    [許志成] 期刊論文 2022-02-16 Selection and warning of evidence-based antidiabetic medications for patients with chronic liver disease -
    [許志成] 期刊論文 2022-12-21 Liver-related long-term outcomes of alpha-glucosidase inhibitors in patients with diabetes and liver cirrhosis -
    [許志成] 期刊論文 2023-01-04 Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetes -
    [許志成] 期刊論文 2024-01-04 Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes -
    [許志成] 期刊論文 2020-05 Liver-related long-term outcomes of thiazolidinedione use in persons with type 2 diabetes -
    [許志成] 期刊論文 2021-01 Thiazolidinediones were associated with higher risk of cardiovascular events in patients with type 2 diabetes and liver cirrhosis -
    [許志成] 期刊論文 2020-12-14 Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis -
    [許志成] 期刊論文 2023-01 The risk of severe hypoglycemia and mortality in patients with type 2 diabetes and discharged with acute liver injury -
    [許志成] 期刊論文 2024-06 Glucagon-like peptide-1 receptor agonist use in patients with liver cirrhosis and type 2 diabetes -
    [許志成] 期刊論文 2021-02 Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: A nationwide population-based cohort study in Taiwan -

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback